iProgen Biotech Inc.
$7,205.00 CAD
- Department
- Global Affairs Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- September 25, 2019 – March 31, 2020
- Reference
- dfatd-maecd:064-2019-2020-Q2-00173
Published purpose
P008256001: The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies. P008256002: The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.